Wong G, Stidley C, Dressler L, Castillo M, Crooks L, Bartow S
Department of Radiation Oncology, St Joseph Cancer Center, Albuquerque, NM 87102, USA.
J Laryngol Otol. 1996 Mar;110(3):243-8. doi: 10.1017/s0022215100133316.
A retrospective study was performed on 61 eligible patients with stage III and IV (AJC/UICC Staging System) squamous carcinomas of the head and neck region who were treated with definitive radiotherapy with, or without, surgery. DNA contents were measured by flow cytometric analysis of archival paraffin blocks and were correlated with clinicopathological findings, tumour response and patient survival. Comparison of variables including treatment modality was performed for identification of significant prognostic factors. There were 28 diploid, 27 aneuploid tumours and the remaining six were questionable. All patients were followed-up for at least two years or until death. Aneuploid tumours had a significantly higher S-phase fraction (percentage S-phase) (p < 0.001). Neither ploidy nor percentage S-phase were found to have predictive value in tumour response or patient survival within the power of a sample size of 61. Twenty of the 27 (74 per cent) aneuploid tumours had a complete response (CR) whereas 19 out of 28 (68 per cent) diploid tumours achieved CR. Five-year survival by the Kaplan-Meier method was 33 per cent for both aneuploid and diploid tumours. However, nodal stage (N stage) was found to have significant predictive value in both tumour response and patient survival. The complete response for stage N0 patients was 96 per cent, N1 patients 61 per cent, N2 patients 60 per cent and 43 per cent for N3 patients (p < 0.002). Similarly, the five year survival for the N0 and N3 groups of patients was 53 per cent and 29 per cent respectively (p < 0.05).
对61例符合条件的头颈部Ⅲ期和Ⅳ期(AJC/UICC分期系统)鳞状细胞癌患者进行了一项回顾性研究,这些患者接受了单纯根治性放疗或联合手术治疗。通过对存档石蜡块进行流式细胞术分析来测量DNA含量,并将其与临床病理结果、肿瘤反应和患者生存率相关联。对包括治疗方式在内的变量进行比较,以确定显著的预后因素。有28例二倍体肿瘤、27例非整倍体肿瘤,其余6例结果存疑。所有患者均随访至少两年或直至死亡。非整倍体肿瘤的S期分数(S期百分比)显著更高(p<0.001)。在样本量为61的情况下,未发现倍性或S期百分比对肿瘤反应或患者生存具有预测价值。27例(74%)非整倍体肿瘤中有20例达到完全缓解(CR),而28例二倍体肿瘤中有19例(68%)达到CR。采用Kaplan-Meier法,非整倍体和二倍体肿瘤的5年生存率均为33%。然而,发现淋巴结分期(N分期)在肿瘤反应和患者生存方面均具有显著的预测价值。N0期患者的完全缓解率为96%,N1期患者为61%,N2期患者为60%,N3期患者为43%(p<0.002)。同样,N0组和N3组患者的5年生存率分别为53%和29%(p<0.05)。